Recent Articles

Patient with Brain Tumor Responds Dramatically to Targeted Therapy

| June 9, 2017 | 0 Comments

Patient with Brain Tumor Responds Dramatically to Targeted Therapy A patient with a papillary craniopharyngioma saw his tumor shrink more than 80 percent after treatment with a targeted drug that inhibits a mutant form of the BRAF protein.See Original Article Better Care for Children with Cancer Linked to Longer Lifespans New data from the Childhood […]

Continue Reading

The ‘Crisis’ of Low HPV Vaccination Rates: A Conversation with Dr. Noel Brewer

| June 8, 2017 | 0 Comments

The ‘Crisis’ of Low HPV Vaccination Rates: A Conversation with Dr. Noel Brewer Following the release of a consensus statement from the NCI-Designated Cancer Centers urging HPV vaccination in the United States, Dr. Noel Brewer discusses the country’s low vaccination rates and how clinicians can help to improve them.See Original Article Study Finds Storytelling Helps […]

Continue Reading

Less Chemotherapy May Be Best Choice for Some Patients with Colon Cancer, Study Shows

| June 7, 2017 | 0 Comments

Less Chemotherapy May Be Best Choice for Some Patients with Colon Cancer, Study Shows A shorter course of chemotherapy following surgery may be preferred to longer treatment for some patients with colon cancer, results of an international collaborative study suggest.See Original Article

Continue Reading

FDA Expands Approval of Pembrolizumab for First-Line Treatment of Non-Small Cell Lung Cancer

| June 6, 2017 | 0 Comments

FDA Expands Approval of Pembrolizumab for First-Line Treatment of Non-Small Cell Lung Cancer FDA approved the immune checkpoint inhibitor pembrolizumab to be used with chemotherapy as a first-line treatment for non-small cell lung cancer. See Original Article

Continue Reading

HPV Vaccination Linked to Decreased Oral HPV Infections

| June 5, 2017 | 0 Comments

HPV Vaccination Linked to Decreased Oral HPV Infections A study of more than 2,600 young adults found that the prevalence of oral infection with four HPV types, including two cancer-causing types, was 88% lower in those who reported receiving at least one dose of an HPV vaccine than in those not vaccinated.See Original Article

Continue Reading

Midostaurin Approved by FDA for Acute Myeloid Leukemia

| June 1, 2017 | 0 Comments

Midostaurin Approved by FDA for Acute Myeloid Leukemia The FDA has approved midostaurin for patients with newly diagnosed acute myeloid leukemia (AML) with mutations in the FLT3 gene. The approval also several other conditions.See Original Article

Continue Reading

Study Identifies Genetic Mutations in Tumors From 10,000 Patients with Metastatic Cancer

| May 31, 2017 | 0 Comments

Study Identifies Genetic Mutations in Tumors From 10,000 Patients with Metastatic Cancer Researchers at Memorial Sloan Kettering Cancer Center have reported the results of an initiative to characterize the genetic mutations in tumors from more than 10,000 patients with advanced cancer treated at the center. See Original Article

Continue Reading

FDA Approves Immunotherapy Drugs for Patients with Bladder Cancer

| May 30, 2017 | 0 Comments

FDA Approves Immunotherapy Drugs for Patients with Bladder Cancer The FDA has approved four immunotherapy drugs—avelumab, atezolizumab, durvalumab, and pembrolizumab—for the treatment of patients with bladder cancer. All four drugs belong to a class of cancer therapies known as checkpoint inhibitors.See Original Article

Continue Reading

New on NCI’s Websites for May 2017

| May 30, 2017 | 0 Comments

New on NCI’s Websites for May 2017 NCI periodically provides updates on new websites and other online content of interest to the cancer community.See Original Article

Continue Reading

Intensive Pre-Stem Cell Transplant Regimen May be Best for Younger Patients with AML, MDS

| May 26, 2017 | 0 Comments

Intensive Pre-Stem Cell Transplant Regimen May be Best for Younger Patients with AML, MDS Results from a large phase III clinical trial suggest that a highly intensive preparatory regimen should be used for younger patients with acute myeloid leukemia or myelodysplastic syndromes preparing to undergo an allogeneic stem cell transplant.See Original Article

Continue Reading